Requires insurance policies to provide coverage for transvaginal ultrasounds during pregnancy.
Summary
A03280, titled the “Eli Parker Levitt Law,” amends New York’s insurance law to require certain health insurance policies and contracts to cover medically necessary transvaginal ultrasounds during pregnancy when those ultrasounds are recommended by nationally recognized clinical practice guidelines. The bill adds this requirement to three separate insurance law provisions governing individual, group, and nonprofit health insurance coverage, so the mandate applies across a broad range of private insurance products.
The bill defines “nationally recognized clinical practice guidelines” as evidence-based guidelines developed through systematic review of evidence, assessment of benefits and risks, and produced by independent organizations or medical professional societies using transparent methods and conflict-of-interest policies. The law is set to take effect on January 1, 2027, and will apply to policies or contracts issued, renewed, modified, altered, or amended on or after that date.
Impact
The bill expands mandated pregnancy-related coverage under New York Insurance Law sections 3216, 3221, and 4303 by requiring insurers to include medically necessary transvaginal ultrasounds when supported by recognized clinical guidelines. This creates a new coverage obligation for individual, small group, large group, and nonprofit health insurance plans subject to those provisions, and may affect insurer benefit design, claims handling, and prenatal care access for insured patients.
Sentiment
The available voting history shows strong and unanimous support for the bill: it passed the Assembly Insurance Committee 24-0, the Assembly floor 145-0, and the Senate floor 59-0. That pattern suggests broad bipartisan or at least near-universal legislative agreement that the coverage mandate should be added to state insurance law.
Contention
No committee transcript or recorded opposition is provided, and the roll calls show no recorded nay votes, so there is no documented legislative contention in the supplied materials. Any policy debate that may have existed is not reflected in the available record; based on the text, the main issue would likely be whether insurers should be required to cover this specific pregnancy-related diagnostic service when medically necessary under clinical guidelines.
Requires that health insurance policies shall provide coverage for follow-up screening or diagnostic services for lung cancer; provides that no patient cost sharing shall be imposed for follow-up screening or diagnostic services for lung cancer.
Requires that health insurance policies shall provide coverage for follow-up screening or diagnostic services for lung cancer; provides that no patient cost sharing shall be imposed for follow-up screening or diagnostic services for lung cancer.
Requires health insurance coverage for mammography by either mammogram and breast ultrasound or breast tomosynthesis for persons with heterogeneously dense or extremely dense breasts.